100% Quality Guarantee
PhD-Level Technical Support
Key Features

Bevacizumab ELISA Kit (GXEL00130)

SKU GXEL00130
Product Type ELISA Kit
Assay Type Quantitative
Detection Method Colorimetric
Sensitivity 98.1 ng/mL
Range 312.5 - 20, 000 ng/mL
Size 96T
Synonyms 12-IgG1, F(ab)-12 IgG1, Fab-12 IgG1, rhuMAb-VEGF, ABP 215, 216974-75-3
$1,162

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

Bevacizumab ELISA Kit

The Bevacizumab ELISA Kit (SKU: GXEL00130) is a high-sensitivity quantitative ELISA assay developed for the quantitative measurement of Bevacizumab in Plasma, Serum. The assay delivers a detection range of 312.5 - 20, 000 ng/mL and a sensitivity of 98.1 ng/mL and is read colorimetrically at 450 nm, making it well suited to quantitative research workflows.

Bevacizumab is a recombinant human IgG1 monoclonal antibody specific for all human vascular endothelial growth factor-A (VEGF-A) isoforms. The humanized anti-VEGF monoclonal antibody, bevacizumab, has been approved by the FDA as a first-line treatment for metastatic colorectal cancer in combination with chemotherapy. The pharmacokinetic properties of bevacizumab in several species have been previously described and are consistent with a typical humanized monoclonal antibody. It was shown in the literature that the surveillance of circulating concentration during maintenance therapy represents a direct and/or indirect factor for some other side effects. Identification of biomarkers for (non-)response and risk factors for adverse drug reactions that might be related to serum concentrations and maintaining the effective concentration of Bevacizumab in order to potentially avoid some side effects with a reliable method might be beneficial.

Supplied with pre-coated microplates and all core reagents, the Bevacizumab ELISA Kit gives you a validated, ready-to-use solution for Bevacizumab research. Get accurate and reliable results with the Bevacizumab ELISA Kit from Assay Genie.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose